Small molecule metabolites: discovery of biomarkers and therapeutic targets
S Qiu, Y Cai, H Yao, C Lin, Y Xie, S Tang… - Signal Transduction and …, 2023 - nature.com
Metabolic abnormalities lead to the dysfunction of metabolic pathways and metabolite
accumulation or deficiency which is well-recognized hallmarks of diseases. Metabolite …
accumulation or deficiency which is well-recognized hallmarks of diseases. Metabolite …
Lysine crotonylation of SERCA2a correlates to cardiac dysfunction and arrhythmia in Sirt1 cardiac-specific knockout mice
HX Chen, XC Wang, HT Hou, J Wang, Q Yang… - International Journal of …, 2023 - Elsevier
Protein post-translational modifications (PTMs) are important regulators of protein functions
and produce proteome complexity. SIRT1 has NAD+-dependent deacylation of acyl-lysine …
and produce proteome complexity. SIRT1 has NAD+-dependent deacylation of acyl-lysine …
Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
H Zhang, L Wang, D Yin, Q Zhou, L Lv, Z Dong, Y Shi - BMC genomics, 2022 - Springer
Background The exact mechanism of atrial fibrillation (AF)-induced heart failure (HF)
remains unclear. Proteomics and metabolomics were integrated to in this study, as to …
remains unclear. Proteomics and metabolomics were integrated to in this study, as to …
Cross-sectional gene-smoking interaction analysis in relation to subclinical atherosclerosis-results from the IMPROVE study
B Maitusong, F Laguzzi, RJ Strawbridge… - Circulation: Genomic …, 2023 - Am Heart Assoc
Background: Smoking is associated with carotid intima-media thickness (C-IMT). However,
knowledge about how genetics may influence this association is limited. We aimed to …
knowledge about how genetics may influence this association is limited. We aimed to …
[HTML][HTML] Moricizine prevents atrial fibrillation by late sodium current inhibition in atrial myocytes
T Zou, Q Chen, C Chen, G Liu, Y Ling… - Journal of Thoracic …, 2022 - ncbi.nlm.nih.gov
Background Enhanced late sodium current (INaL) is reportedly related to an increased risk
of atrial fibrillation (AF). Moricizine, as a widely used anti-arrhythmia drug for suppressing …
of atrial fibrillation (AF). Moricizine, as a widely used anti-arrhythmia drug for suppressing …
Metabolomics Analysis Identifies Differential Metabolites as Biomarkers for Acute Myocardial Infarction
J Zhou, HT Hou, Y Song, XL Zhou, HX Chen, LL Zhang… - Biomolecules, 2024 - mdpi.com
Myocardial infarction (MI), including ST-segment elevation MI (STEMI) and non-ST-segment
elevation MI (NSTEMI), is still a leading cause of death worldwide. Metabolomics technology …
elevation MI (NSTEMI), is still a leading cause of death worldwide. Metabolomics technology …
Metabolomics and Biomarkers for Paroxysmal and Persistent Atrial Fibrillation
LL Zhang, WH Lin, CY Di, HT Hou… - Journal of the …, 2024 - Am Heart Assoc
Background Atrial fibrillation (AF) is the most common type of arrhythmia worldwide and is
associated with serious complications. This study investigated the metabolic biomarkers …
associated with serious complications. This study investigated the metabolic biomarkers …
[HTML][HTML] Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation
M Zhao, X Liu, X Bu, Y Li, M Wang, B Zhang, W Sun… - PeerJ, 2022 - peerj.com
Rivaroxaban, an oral factor Xa inhibitor, has been used to treating a series of
thromboembolic disorders in clinical practice. Measurement of the anticoagulant effect of …
thromboembolic disorders in clinical practice. Measurement of the anticoagulant effect of …
Further Advances in Atrial Fibrillation Research: A Metabolomic Perspective
L Arbeloa-Gómez, J Álvarez-Vidal… - Applied Sciences, 2022 - mdpi.com
Atrial fibrillation involves an important type of heart arrhythmia caused by a lack of control in
the electrical signals that arrive in the heart, produce an irregular auricular contraction, and …
the electrical signals that arrive in the heart, produce an irregular auricular contraction, and …
Multi-omics approaches in research of cardiovascular diseases
HE Guo-Wei - Scripta Medica, 2022 - aseestant.ceon.rs
Cardiovascular diseases remain number 1 killer world-wide. New technologies, particularly
the novel approaches at genetics, transcriptomics, proteomics and metabolomics levels …
the novel approaches at genetics, transcriptomics, proteomics and metabolomics levels …